Whitney is studying the
interactions between the chemokine fractalkine and its
receptor CX3CR1 and the role they play in the adhesion
of prostate cancer cells to the bone marrow endothelium
and their extravasation into the bone stroma. Whitney joined
the lab in August 2005.
Whitney
Jamieson